跳至主要内容
临床试验/NL-OMON43605
NL-OMON43605招募中不适用

Minitub: Prospective registry of Sentinel Node (SN) positive melanoma patients with minimal SN tumor burden who undergo Completion Lymph Node Dissection (CLND) or Nodal Observation - EORTC 1208: MINITUB

European Organisation for Research in Treatment of Cancer (EORTC)0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Histological evidence of primary cutaneous melanoma
  • * Metastases solely confined within the SN:
  • * in the sub-capsular space (with no parenchymal infiltration) and with a maximum diameter of the largest metastasis not greater than 0.4 mm
  • * regardless of the site, any sub-micrometastasis with a maximum diameter not greater than 0.1 mm
  • If there is more than 1 metastatic SN, the patient will be still eligible provided that all involved SN have minimal tumor burden, regardless of the amount of positive SNs and the basin of interest
  • * Absence of clinically apparent metastatic disease at the time of or before undergoing a SN procedure
  • * Age >=18 years
  • * Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial
  • * Before patient registration, written informed consent must be given according to ICH/GCP, and national/local regulations.

排除标准

  • * No previous SN procedure for locally recurrent melanoma or uncertain malignant disease, such as atypical Spitz tumor/naevi
  • * No history of a previous melanoma (preceding the melanoma which prompted the SN biopsy)
  • * No history of any other malignancy within the past 5 years, except for non-melanoma skin cancer (Basal Cell Carcinomas or Squamous Cell Carcinomas) and in situ cervical cancer
  • * Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial.

研究者

发起方
European Organisation for Research in Treatment of Cancer (EORTC)

相似试验

Minitub: Prospective registry of Sentinel Node (SN)... | 临床试验